Stocks News

LAST PRICE
57.8600
TODAY'S CHANGE (%)
Trending Down-0.7200 (-1.2291%)

Bid / Lots
23.5000/ 1
Ask / Lots
59.3500/ 4
Open / Previous Close
57.8800 / 58.5800
Day Range
Low 57.3600
High 59.3500
52 Week Range
Low 22.3400
High 62.4000
Volume
1,192,779
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 27, 2024
- Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024, from 4:05PM ET on Wednesday Nov 27, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
  
  REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will host an investor webcast to provide clinical updates from its RAS(ON) inhibitor portfolio.
Nov 7, 2024
- DJ Revolution Medicines Is Maintained at Buy by Needham, from 3:49PM ET on Thursday Nov 07, 2024 by Dow Jones
  3:49PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 15:49 ET (20:49 GMT)
- DJ Revolution Medicines Is Maintained at Buy by HC Wainwright & Co., from 3:42PM ET on Thursday Nov 07, 2024 by Dow Jones
  3:42PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 15:42 ET (20:42 GMT)
- DJ Revolution Medicines Is Maintained at Overweight by JP Morgan, from 1:00PM ET on Thursday Nov 07, 2024 by Dow Jones
  1:00PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 13:00 ET (18:00 GMT)
- DJ Revolution Medicines Is Maintained at Overweight by Piper Sandler, from 10:10AM ET on Thursday Nov 07, 2024 by Dow Jones
  10:10AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 10:10 ET (15:10 GMT)

Nov 26, 2024
- Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 6:53AM ET on Tuesday Nov 26, 2024 by PR Newswire
  6:53AM ET on Tuesday Nov 26, 2024 by PR Newswire
  Companies Mentioned: NUVL
- Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 6:52AM ET on Tuesday Nov 26, 2024 by Dow Jones
  6:52AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: NUVL
Nov 22, 2024
- European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week, from 11:04AM ET on Friday Nov 22, 2024 by MT Newswires
  11:04AM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: ING, BBVA, TRIB, AMRN, OPRA, GNFT, AKTX, BNTX, AZN, SLN, TCBP, ASND, ADAP, SAN, BDRX, EDAP
Nov 20, 2024
- Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Newsfile
  2:46PM ET on Wednesday Nov 20, 2024 by Newsfile
  Companies Mentioned: PCVX
- Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones
  2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: PCVX
Nov 19, 2024
- Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing, from 4:53PM ET on Tuesday Nov 19, 2024 by MT Newswires
  4:53PM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: PCVX
Nov 18, 2024
- European Equities Traded in the US as American Depositary Rise in Monday Trading, from 11:21AM ET on Monday Nov 18, 2024 by MT Newswires
  11:21AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: NTZ, NVO, TEF, SQNS, GRFS, AMRN, OPRA, AKTX, MREO, SLN, EVAX, BP, TCBP, ASND, ADAP, BDRX
Nov 15, 2024
- DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BBVA, LYG, PUK, ARGX, AKTX, MREO, BCYC, BNTX, EVAX, BTI, TCBP, DBVT, ASND, CLLS, SAN, BDRX

Revolution Medicines Inc
NASDAQ:RVMDUnited States

Search Criteria

Nov 27, 2024

Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024, from 4:05PM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 7, 2024

DJ Revolution Medicines Is Maintained at Buy by Needham, from 3:49PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Revolution Medicines Is Maintained at Buy by HC Wainwright & Co., from 3:42PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Revolution Medicines Is Maintained at Overweight by JP Morgan, from 1:00PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Revolution Medicines Is Maintained at Overweight by Piper Sandler, from 10:10AM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Nov 26, 2024

Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 6:53AM ET on Tuesday Nov 26, 2024 by PR Newswire

Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 6:52AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 22, 2024

European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week, from 11:04AM ET on Friday Nov 22, 2024 by MT Newswires

Nov 20, 2024

Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Newsfile

Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm, from 2:46PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing, from 4:53PM ET on Tuesday Nov 19, 2024 by MT Newswires

Nov 18, 2024

European Equities Traded in the US as American Depositary Rise in Monday Trading, from 11:21AM ET on Monday Nov 18, 2024 by MT Newswires

Nov 15, 2024

DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires